These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5140868)

  • 21. Chemotherapy of experimental metastatic brain tumors in female Wistar rats.
    Hasegawa H; Shapiro WR; Posner JB
    Cancer Res; 1979 Jul; 39(7 Pt 1):2691-7. PubMed ID: 445473
    [No Abstract]   [Full Text] [Related]  

  • 22. [Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions].
    Volm M; Kaufmann M; Mattern J; Wayss K
    Schweiz Med Wochenschr; 1975 Jan; 105(3):74-82. PubMed ID: 1121657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chemotherapy of inoperable cancer of the stomach].
    Raevskiĭ IG
    Sov Med; 1974 Oct; (10):30-5. PubMed ID: 4428239
    [No Abstract]   [Full Text] [Related]  

  • 24. Study on the sensitivity test of carcinostatic agents by acid phosphatase activity.
    Imaizumi M
    Nagoya J Med Sci; 1972 Mar; 34(4):315-33. PubMed ID: 4665966
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
    Hill GJ; Larsen RR
    Oncology; 1972; 26(2):206-22. PubMed ID: 4626137
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combined cytostatic treatment of solid tumours with cyclophosphamide (Endoxan), vincristine, methylaminopterin (Methotrexate) and 5-fluorouracil].
    Brincker H
    Ugeskr Laeger; 1971 May; 133(19):926-9. PubMed ID: 5559763
    [No Abstract]   [Full Text] [Related]  

  • 28. [Characteristics of growth and sensitivity to cytostatics of Walker 256 carcinosarcoma in randombred and Wistar rats].
    Karaivanova MK
    Eksp Med Morfol; 1974; 13(4):237-42. PubMed ID: 4219353
    [No Abstract]   [Full Text] [Related]  

  • 29. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 30. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 31. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
    Heuson JC; Sylvester R; Engelsman E
    Eur J Cancer (1965); 1980; Suppl 1():113-7. PubMed ID: 7032920
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: Cancer of the prostate.
    Murphy GP
    Cancer; 1973 Nov; 32(5):1089-91. PubMed ID: 4127978
    [No Abstract]   [Full Text] [Related]  

  • 33. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
    Kline I
    Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
    [No Abstract]   [Full Text] [Related]  

  • 34. Systemic chemotherapy of advanced head and neck malignancies.
    Dowell KE; Armstrong DM; Aust JB; Cruz AB
    Cancer; 1975 Apr; 35(4):1116-20. PubMed ID: 1116105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy of malignant melanoma.
    Luce JK
    Cancer; 1972 Dec; 30(6):1604-15. PubMed ID: 4565819
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute leukemia complicating metastatic breast cancer.
    Davis HL; Prout MN; McKenna PJ; Cole DR; Korbitz BC
    Cancer; 1973 Mar; 31(3):543-6. PubMed ID: 4511910
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of metastasizing solid tumors with cyclophosphamide, methotrexate, vincristine and 5-fluorouracil].
    Fritsch H; Castor H; Drings P; Moskwa G
    Verh Dtsch Ges Inn Med; 1973; 79():1373-6. PubMed ID: 4790188
    [No Abstract]   [Full Text] [Related]  

  • 39. The phase II study: some reflections, particularly concerning disseminated breast cancer.
    Ahmann DL
    Cancer Chemother Rep 3; 1972 May; 3(1):29-32. PubMed ID: 5049705
    [No Abstract]   [Full Text] [Related]  

  • 40. A phase 2 evaluation of 1-(2-chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea (NSC 95441) in patients with advanced breast cancer.
    Ahmann DL; Bisel HF; Hahn RG
    Cancer Res; 1974 Jan; 34(1):27-30. PubMed ID: 4809462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.